Virtuix Holdings Inc. (VTIX) Earnings Call Transcript
August 20, 2026
Earnings Call Speaker Segments
So with that, I'm going to hand things over to Mr. Gukuluk. Go ahead, sir. Thanks, operator, and good morning to all of you. Appreciate you being with us. To start, a quick word about timing. We switched auditors not long ago. Eisner Amber was brought on as our independent registered public accounting firm; they are regularly cited as a top mid-tier accounting and advisory practice, so working with them is something we're genuinely thrilled about; the changeover meant we needed extra time to finish the quality review, which is the reason our filing slipped by a few days; but our form, thank you, has been filed now; so let's go through what we posted for the first quarter. quarter of fiscal year 2027. In my view, this first quarter ranks among the strongest commercial quarters in our company's recent history. And I want to use most of my time this morning to explain why that's the case. Before getting into that, here's a quick overview for anyone new to our story. So, we are Vertrix. We develop AI-driven full-body simulation systems and are a leader in that space; we've traded on the NASDAQ global markets under the ticker VTIX since our debut on January 27, 2026. Our technology makes natural full body movements possible in 360 degrees, walking, running, crouching, strafing, and jumping in every direction, inside video games, simulations, and so on. and other AI-generated worlds. OmniOne is our flagship product, and it's the most advanced omnidirectional treadmill we've built to date. And the folder comprises of five products now, protected by more than 25 patents; on the consumer side we have OmniOne, OmniOne for Quest, and OmniOne Core. For industrial training, robotics, healthcare, and other enterprise applications, there's OmniOne Enterprise. And we have Virtual Terrain Walker, VTW, which serves as our defense platform. simulation system. We know hardware, and we've shown we can execute. Our manufacturing facility is up and running and stands ready to handle higher production volumes. Our strategy centers on a multi-use platform, with high-volume consumer sales that we intend to complement through high-value defense and enterprise contracts, along with recurring revenue generated by software licensing, subscriptions, and our custom simulation developments. What stands out to me about this quarter specifically is just how impressive the parties now working with our technology are. Within only a few months, we sold our first OmniOne Enterprise System to Tesla. NASA chose us for a year-long Moon and Mars mission; we took on the role of lead systems integrator on the US Marine Corps training project. And naturally, we rolled out our made-for-Meta certified products together with Meta; so that amounts to meaningful validation for a platform that got its start in consumer gaming and is now reaching into various end markets; so before we dig deeper, let me take you through the quarter's highlights. When it comes to demand, orders are the headline figure here. Demand for OmniOne systems jumped 72% compared to a year earlier, and orders are roughly 150% higher — about two and a half times what we saw in the same stretch a year ago — ever since our June launch of OmniOne for Quest alongside Meta; so on that front, those growth figures look quite strong. Turning to unit economics, gross profit rose 29% versus a year ago, while gross margin widened to 30%, up from 17% during the comparable period a year earlier. That works out to about 13 percentage points of gain. We closed the quarter holding $7.4 million in cash. From a strategic standpoint, it was quite a busy quarter. As you know, we rolled out our major Meta products together with Meta, and that's gotten off to a strong beginning, driving solid order growth in our consumer business. Our defense business keeps growing. We got picked to serve as lead systems integrator for building an infantry fire team trainer for the US Marine Corps. We likewise moved into counter drone training for the Marine Corps; over in our enterprise business, as I mentioned, we're currently working with Tesla and with NASA, and we additionally signed a partnership with Sirica Therapeutics covering use of OmniOne in autism therapy for children. One clarification before Thomas walks through the numbers afterward. Reported net sales in fact fell year-over-year, landing at roughly 800,000 versus 1 million — that stems from timing, not demand — because the earlier quarter contained the last shipments from our legacy only one order backlog, which covered orders built up from when our pre-order period started in August 2020 through 2023, and that backlog has now been fully cleared. Revenue this quarter, by contrast, was generated by sales to new customers. All right. And we think new orders serve as the stronger forward-looking signal of the demand we're witnessing today; so let me remain on that subject, since I consider it the most significant trend in our business at present. So we formally introduced OmniOne for Quest together with Meta in late June; and via that META program, OmniOne holds certification for the META ecosystem, meaning the Quest ecosystem. META has sold over 20 million Quest headsets, which gives OmniOne reach into the world's biggest XR user base, with an estimated 6 million active users. And those users can now pair OmniOne with headsets they already have. game library they already possess, in a plug-and-play experience; so this substantially widens our addressable markets; and the impact on our order profile showed up right away. New orders have risen roughly 150% since that launch. And we expect that trend to carry into the current quarter. We also see room for further growth in that area. We're looking into joint marketing possibilities with Meta, and even more importantly, bundling the Meta and the Vertex products so we can provide a complete system — OmniOne for... for Quest plus a Quest headset — to customers together. So we feel we've barely scratched the surface of what our collaboration with Meta can offer. Now on the defense side — like I said earlier, Virtuex is acting as the lead systems integrator on an infantry fireteam trainer being built for the U.S. Marine Corps, and KBR, our strategic partner, is backing us on that. That distinction matters quite a bit. Virtuex isn't just handing over one component of this system; our job is to integrate the whole solution and hand the Marine Corps the finished training system. So what that system does is place a four-person — a four-marine — fire team onto omnidirectional treadmills, equipped with M4 rifle surrogates and MetaQuest headsets, and they train together through scenarios covering close-quarter battles, patrols, and tactical decision-making. In the quarter we just finished, we brought on ABRT as our partner to supply a tracked weapon system, an instructor tool, and immersive training content for the program. Delivery to the U.S. Marine Corps out in Quantico, Virginia, should happen in Q4 of 2026. Let me also clarify — this infantry fire team trainer stands apart from our virtual terrain walk system, VTW, which is the one that relies on AI-driven Gaussian splatting to turn 360-degree camera footage into photorealistic, walkable, geospecific terrain. It shrinks the time needed to build virtual worlds from weeks down to just hours. That's VTW — the system whose slogan is walk the trail before you fight on it. Explore the battlefields before we put boots on the ground.
So VTW is a program where the U.S. Air Force gave us a Phase I CBER award, and that work is underway as we speak. Also during this quarter, we entered a fast-growing new defense segment: the market for counter drone training. As you're aware, OmniOne has been built into Leetech's counter UAS personal trainer, an AI-enabled platform that recreates military training ranges so that counter drone marksmanship training has a realistic feel. Once Omni is added, trainees can walk naturally through virtual environments, move through buildings, and communicate over tactical radios while engaging drones with realistic ballistics, in both individual and multi-user scenarios. That system is set to be evaluated by the U.S. We're working with Marine Corps Training and Education Command, which is based in Quantico, Virginia, and we also have teams involved from 29 Palms and Camp Pendleton. It probably goes without saying that counter drone training sits near the top of the list when it comes to the priorities growing quickest among Western militaries right now. From our standpoint, that makes this a really thrilling step forward. Now I'll walk through how our defense business is expanding. At present we have engagements underway with the U.S. Air Force, the Marine Corps, the Army, and the Navy, and during this quarter we added the Air National Guard as well. On the U.S. Air Force side, we carry a NAFW Works Ciber Phase I award tied to VTW, and beyond that we've made test unit sales to the U.S. Air Force Academy as well as to Yokota Air Force Base. Also in this quarter, as I noted earlier, we handed over the initial OmniOne unit to a Pennsylvania Air National Guard detachment located in Horsham, where they'll assess our platform for military virtual reality instruction. That marks the first time we've deployed with the Air National Guard. We remain the lead systems integrator for the infantry fire team trainer alongside the US Marine Corps, as previously stated, and the Marine Corps Training and Education Command is now beginning evaluation of our counter drone trainer. Regarding the U.S. Army, a single unit has been purchased by the U.S. Military Academy at West Point. On the U.S. Navy side, we've entered into a Cooperative Research and Development Agreement with the U.S. Navy's Naval Postgraduate School. There's a great deal of momentum built up in a very brief period, and we intend to sustain that powerful early traction and carry it onward toward larger awards and contracts. Beyond that natural growth, as we've mentioned previously, our board's special committee is right now evaluating potential acquisitions within the defense sector — specifically around defense training and services — targeting businesses whose yearly revenue falls between $10 and $50 million. More precisely, we're focused on firms that would hand us instant access to, on top of that revenue, government contract vehicles, sales channels, recurring defense revenue, and the past performance credentials that matter so much when competing for major government contracts. Keep watching, since additional announcements are coming on that front. Now, moving past defense, our enterprise segment is picking up serious momentum as well. Tesla bought an OmniOne Enterprise System—the first one we've sold—for the division working on its Optimus humanoid robot. Among the uses is a platform for robotic teleoperation, allowing a person to operate a humanoid unit remotely in real time. At present, training and supervision of humanoids lean greatly on teleoperation. For that job, a full-body motion interface is just logical. On top of that, at the Augmented World Expo we took home our second Augie Award in a row, this time for Best Interaction Product, again honoring OmniOne as a component of a humanoid robot teleoperation setup developed by the University of Central Florida. That gives us one more piece of proof that our technology serves as a crucial input device for Enterprise XR use cases. Finally, NASA chose us for its Moon and Mars Exploration Analog Mission. Throughout this study, which lasts a year, OMNI-1 will assist with simulated extravehicular activities. It kicks off in 2007, with 4 volunteers residing in a habitat of 650 square feet to mimic astronaut performance ahead of future deep space missions. The important thing is that enterprise deals of this kind bring in high-margin hardware income, along with recurring software licensing revenue and possible services income tied to the hardware purchase. So our enterprise segment represents one more element of our overall strategy. And as you're aware, we've additionally been looking into healthcare and therapeutics opportunities for OmniOne, which might become a significant new vertical for us, and during this quarter we achieved notable headway there. We entered a strategic partnership with Serica Therapeutics, which focuses on advanced AI-driven autism therapy for children. We delivered 2 OmniOne systems to Syracuse Treatment Center in the San Francisco Bay Area. They've shared plans to open roughly 100 treatment centers across the country. To give you a sense of scale, there are roughly 12,000 ABA therapy centers across the United States, and in our view that represents a channel with real scalability potential for even a single healthcare participant. This commercial tie-up with Sirica extends the university initiatives we've referenced previously. At Rutgers University's WinLab, OmniOne is being applied to AI-assisted neurodivergent therapy, and the team there is actively developing an autism therapy application aimed at children. In parallel, Florida Gulf Coast University's Marriott College of Health and Human Services is evaluating OmniOne for both physical therapy and neurorehabilitation. Our belief is that full-body motion within AI-enabled environments could play an expanding role across next-generation healthcare and therapeutic applications. So we plan to keep pushing these efforts forward and possibly see healthcare and therapeutics become another major market for our technology. With that said, I'll pass the call to Thomas so he can take us through the financials.
Thanks, Jan, and good morning to all of you. For the first quarter of fiscal 2027, net sales came in at $767,000, versus $1 million during the same period a year earlier — that's a 26% decline. As Jan pointed out, the comparable quarter last year benefited from shipping the last batch tied to a sizable legacy backlog of OmniWin orders that had built up from when our pre-order window opened in August of 2023, while this quarter's revenue came from customers we've newly brought on board. OmniOne new orders actually rose 72% compared with a year ago, and since we launched OmniOne for Quest together with Meta, new orders have climbed roughly 150%; that momentum is carrying into the quarter we're in now. The metric I'd most like you to focus on is gross margin. Gross profit came to $227,000, up 29% from $176,000 a year earlier. As a share of revenues, gross margin rose about 13 percentage points, going from 17% to 30% in this quarter. Higher selling prices on the full OmniOne system, relative to the year-ago period, drove that gain. Now on to operating expenses: total opex rose by 1.9 million, or 86%, reaching 4.1 million, up from 2.2 million in the comparable period last year. The main driver there was a $2.1 million rise in general and administrative, which went to $3.1 million from $1 million, reflecting the cost of running a public company that mostly wasn't present in the year-ago quarter — that quarter came before our NASDAQ listing — and the cost of running the public company. Inside that increase, professional services made up $1.2 million, insurance accounted for $0.2 million, and non-cash stock compensation was $0.7 million. Selling expenses went the opposite direction, dropping about $0.3 million to $0.7 million, while development expenses rose roughly 0.1 million to 0.3 million as we brought on staff to push forward OmniOne's request. Loss from operations was $3.9 million, versus $2 million a year earlier; and the loss for the quarter totaled $7.2 million, compared with $2.3 million in the prior year period. It's important to grasp what makes up that loss — roughly $4 million of it consists of non-cash charges, among them $2.5 million of largely non-cash interest expense, which takes in an amortization of debt discount on our convertible notes, a $0.6 million financing expense related to our warrant modifications, and a $0.4 million loss on extinguishment of debt, partly offset by a $0.4 million gain on the change in fair value of financial instruments. These items stem from capital we've raised, not from how the business is operating. Net loss per basic and diluted shares was 0.22, compared with $0.28 in the year-ago period, which reflects a much larger weighted average share count after our listing. Before interest, income taxes, and depreciation and amortization, further adjusted to exclude stock-based compensation and certain non-cash and non-recurring items. Our view is that this provides investors with a better picture of how our continuing operations are performing, since it strips out the non-cash charges and financing-related items I just went over. For the first quarter of fiscal 2027, adjusted Able to Loss came in at negative 3.1 million, versus negative 1.9 million a year earlier. That swing from one year to the next comes from the step-up in public company operating expenses, not from unit economics, which got better. A full reconciliation of net loss — the GAAP measure most directly comparable to adjusted EBITDA — appears in the financial tables of yesterday's press release. Moving on to the balance sheet: cash and cash equivalents stood at $7.4 million as of June 30, 2026, down from $9.5 million at March 31, 2026, a decrease of roughly $2 million. Inventory rose about $0.2 million, reaching $1.4 million, as we build up to support the order growth Jan described earlier. Cash used in operating activities totaled $3.3 million for the quarter, against $1.5 million in the prior year period, with the rise reflecting those stepped-up public company costs plus working capital put into inventory. Total assets came to $12.6 million, versus $14.8 million at fiscal year-end. Total liabilities were $15.7 million, compared to $13.7 million, and that includes $10.7 million of notes payable net of discount, up from $7.8 million at March 31st. Total stockholders' equity was a deficit of $3.1 million, compared with positive equity of $1.1 million at fiscal year end. That $4.2 million change reflects the quarter's net loss of $7.2 million, partly offset by a $3 million increase in additional paid capital from financing and equity activities during the year. We're managing the balance sheet to support the growth opportunity ahead of us, and with that objective in mind, we will keep evaluating our capital structure.
John, you have the floor. Thanks. My apologies for that. For whatever reason, my call got disconnected. Are we on the...
slide 16, priorities and outlooks? That's correct, John. Yes, I just...
Yes, that's right. Thanks a lot. Great. Thanks, Thomas. Okay. So as we look forward, there are six priorities that are clear to us. The first one is speeding up growth in consumer revenue. The order momentum we've seen since OmniOne launched for Quest with Meta is the single most significant trend in our consumer business right now, and what we're focused on is keeping that momentum going and working alongside Meta to speed up revenue growth. And in our view, we've barely begun to tap the marketing opportunities that exist with Meta. The second is pushing our defense programs forward toward bigger awards. That means getting the Marine Corps infantry fire team trainer to Quantico in the fourth calendar quarter of this year, wrapping up our Air Force phase one Cibber and working to move that into a phase two, moving our counter drone trainer ahead toward possible awards, and also looking into further partnerships and programs we could take part in. The third is pushing forward on defense M&A. What we're aiming for is closing one or more acquisitions generating $10 million to $15 million in annual revenue that would bring government contract vehicles, past performance, sales channels, and recurring defense revenue. The fourth is growing enterprise sales. We plan to build on the Tesla sale, the NASA collaboration, and all our other recent enterprise traction in order to grow high margin OmniOne enterprise sales. The fifth is building out our healthcare and therapeutics vertical, which we think could turn into a third large end market for our technology. That means creating the channel alongside Circa Therapeutics and other ABA partners and securing clinical validation from our university research collaborations. And the sixth, in the end, is driving toward profitability. We plan to build on the 30% gross margin from this quarter, keep growing revenue, and bring in high-value defense and enterprise contracts as we push toward profitability; in our view, Virtuix is well positioned to turn the momentum we have now into long-term growth and value for our shareholders. Okay, with that said, we'll now open up the call for questions. Operator?.
Alright, good morning to Jan and the whole team. It's really encouraging to witness this momentum carrying forward. Perhaps I could kick things off with a question, Jan, regarding a few of the main growth catalysts you anticipate for this year. You mentioned the made for meta partnership, clearly. That's a significant catalyst that I think only got underway in June. As we consider the, I suppose, latter half of this year, I'm moving toward the holiday season. Could you just speak to how this made for meta partnership, I suppose, is contributing incrementally, I guess, to the game portfolio and the strength of demand, compared with, say, where Virtuix stood last year going into the holiday season. Thanks.
Yeah, hi Jack, morning. Appreciate you hopping on. So, that powerful momentum we talked about — the kind that kicked off when our Meta product launched — we're still observing it during this quarter. Because of that, our belief is it can keep going. This isn't merely some one-off flash in the pan following the launch, the way things appear at the moment. It will carry on. Why? Well, when you consider it, Meta has moved more than 20 million headsets according to recent estimates, and there are 6 million active users who are now able, for the very first time, to purchase our products straight away and enjoy them alongside the headsets and games they already own. That's a really appealing option at a favorable price, plus it widens our addressable market — that was the intention from the start, and it appears to be delivering, since it turns into significant growth in sales and orders, 2.5x compared to the prior level. So for the back half of the year, that looks encouraging, particularly as we head into our holiday season.
All right, that sounds good. And as part of that, I suppose what we have here on the production side of the business is this equation. Could you briefly discuss what your capacity looks like right now? I believe you've actually managed to make a fair number of those Omni units each month. Has high-volume manufacturing gotten underway ever since the meta relationship was made public? And also just speak to your broader capacity growth, I suppose, along with the run rates you're seeing at present.
Right, right. We've got the capacity in place, and the production side too — the facility and the capacity are solidly built out. At this point we're definitely running at full tilt, turning out units and keeping up with what's needed. On the manufacturing front, though, we're ready and able to handle the demand we're seeing. As I believe we mentioned earlier, at present we can produce as many as 3,000 units per month or thereabouts, which works out to roughly $100 million in revenue over a year.
Great, and then — you know what — if we move over really fast to the defense side, well, obviously you're discussing your M&A approach here, focused on opportunities with revenue of roughly 10 to 50 million. Right. It seems like a handful of prospects exist in your pipeline. Before we dive into the acquisitions, though, I'd say could you just mention what you've been seeing lately regarding organic growth in the defense sector? You're now in every arm of the US government, as I understand it. Could you perhaps provide an update on what feedback you're getting from each, you know, from the actual troops who are using this in training modes today — is there potential for expansion in follow-on orders? Thanks.
Sure, absolutely. When you look at it, simulators have long existed in the military for planes. There are simulators for ground vehicles, for tanks. But for boots on the ground, for infantry, there was never a simulator until now, and that's because of what we've built. Infantry war fighters are able to move through virtual settings for training purposes, for planning missions, for rehearsing missions; and in our view that represents a groundbreaking capability for the US military that simply wasn't available previously; which explains the traction and enthusiasm we're witnessing, from the Marine Corps, from the Air Force, and from the other branches too. Over a very short span — I'd call it a very fast window — I actually only kicked off this push roughly 12 months ago, and at this point we're already engaged with all 4 major branches of the US military within the US, tied into assorted programs and projects and awards that we're advancing. And additional things are coming down the road too. There are lots more different use cases where technology can prove genuinely valuable in the setting of military training. So what we're aiming for is to push those projects ahead into the next stage, phase 1, CBER into phase 2, to CBER, to shift these pilot programs toward possibly larger awards and larger rollouts to, you know, military installations and customers and so forth. So we view it as a significant piece of our business that can truly fuel growth and meaningful revenues, but also...
Gross margin from here on out. Jan, could I possibly pose just one additional follow-up question. Obviously there are many distinct avenues for growth, many projects underway involving large... extremely large, highly established businesses. Clearly, Made for Meta is the 800 pound gorilla here. Yet you also have considerable momentum building in the defense space, with possible acquisitions coming. How do you expect Virtuix's revenue profile to develop, I suppose, across those segments during the next 2 to 5 years? Will everything be speeding up in a hockey stick-like fashion? Does one arrive sooner or more quickly compared to the other? And then one becomes the quicker, longer-term component? I would simply like to hear your perspective on that, plus how it affects gross margin over the longer term.
Right, right, thanks for that. Yeah, and one more thing — something I constantly emphasize to everyone on the team, and it's also part of how we operate, is keeping our focus tight. Consumer and defense, without question, are where our attention is concentrated most right now. Meanwhile, enterprise and healthcare are coming up and expanding behind the scenes. When you think about timing, consumer is really what's fueling the bulk of our growth and revenue at present, especially since the major driver on that side is the collaboration we have with Meta. In our view, we're just at the beginning of that and have barely touched what's achievable. So that's what's underway right now. On the defense military side, there's considerable momentum, and we're working toward larger awards and larger contracts; I believe we put out word on that, and reaching those bigger awards is likely to land next calendar year, roughly fiscal year 2028. We're pushing toward that. When it arrives, though, it may come as a step change — landing one large award clearly delivers an immediate, sizable effect on revenue. So consumer and defense are our central areas of focus. That said, enterprise is emerging, with different pockets of demand and applications that look quite interesting, such as the human robots application — robots — which might turn into a meaningful revenue stream down the road; and then healthcare in particular, in my view, could grow into a third major vertical alongside consumer and defense. The healthcare market has the potential to become a large vertical. It isn't yet a central focus for our company, since we're continuing to advance development with Sirica and Rutgers, but the potential there is substantial, especially given roughly 12,000 ABA centers across the country that could adopt our technology, along with a private market on top of that. It could be a major vertical, though it will arrive somewhat later; the approach is more staggered, because we don't want to be pulled in a thousand directions simultaneously. We remain focused on consumer, defense, and enterprise as it develops, and then health care.
This could grow into a substantial market down the road. Alright, I genuinely appreciate that extra detail; that covers everything on my end. I'll be following how things develop. Thank you.
Morning, folks. Are you both able to hear me? Hi, good morning, Gauchy. Yep, morning. Yans, nice work on that order figure. That's real progress. Could you walk me through how this works a little? If a customer puts in an OmniOne order right now, about how much time passes before it goes out. I'm attempting to work out what portion of that 72% ends up in the coming quarter and what portion comes after.
Right, we get it out the door in a matter of days, though the Meta product's launch happened in late June. As a result, just a modest share of it landed in the quarter before this one. So honestly this quarter is really where that momentum keeps building; and as for those revenues, my sense is you'll be seeing that during this quarter.
Great, got it. So you mentioned the Quest offering becoming dominant, meaning you don't have a few months' worth of data yet, and most of the auto growth is coming from Quest. Is that a full system standing on its own, and does that mix tend to move the margin toward that 40% goal?
Right, it isn't a full system at this point. Omni on for Quest is a standalone Omni treadmill that operates alongside Quest, and we're exploring bundling. That's among the discussions we're having with Meta — bundling Omnion for Quest together with an actual Quest headset and providing a full system. But on the margin side, I believe we just closed it; we're driving that margin on our OmniOne consumer units on a per-unit basis, on a sort of unit economics basis, to near 40%. So our goal is to maintain that, and we'll see how it develops over time as the mix shifts.
Yes. A few people may have posed this already. My connection cut out. So I'll put it forward once more. In the release, you mentioned combining Vertrix alongside Metaproduct. Is that a significant thing that might be available during the holiday period, or does it lean more toward being a fiscal 28 discussion?
This is something we are discussing right now. So we're hoping to wrap it up here. Yes.
Okay, regarding the t-con delivery timing you brought up — the marine, a firearm trader. During our previous conversation, I believe you said the delivery system might be, the initial system around September, and at this point we're sort of moving to the fourth quarter. Is that timeline kind of getting tighter on their side, or has the scope been altered, and does it still fall within this fiscal year?
For revenue, yes. We intend to display that and get it to Quantico during the fourth calendar quarter of this year; and then with the aim of pushing that ahead toward larger rollouts. Now, when that happens is difficult to predict. That's one area of uncertainty when working with the government — the timing of when funds become available, when contracts are able to proceed; so that remains uncertain. But our goal is to deliver this initial system here to Quantico, which.
during this year's fourth calendar quarter. Alright. You said defense revenues would only meaningfully show up in fiscal terms. So is this about how we define meaningful, or should we expect nothing at all from defense in fiscal 27?
We do anticipate certain revenues during this fiscal year, since there are all those different projects included under the Syberfees One Award, as an example. But when it comes to bigger contracts involving a major rollout across, you know, multiple installations or a phase two Cibra award, whatever that might be, I would say that's more probable in the following fiscal year rather than this one.
Regarding the resale rate for Omni Arena, I understand you generated roughly $150,000. Is that a form of resale? Is this a one-time occurrence, or is an actual secondary market starting to take shape here?.
No, OmniArena operates in maintenance mode; we keep serving the customers we already have. We keep earning revenues in that area through Omnicare maintenance agreements, through game play, by selling replacement parts, and via secondary sales too. That said, I wouldn't call it a major driver or a large market, but we do facilitate it.
wherever that's required. All right. Then for my final question, is there anything you can share about the multiples on the M&A front? You mentioned revenue between 10 and 50 million. What sort of multiples do businesses like those typically command?
Yeah, that varies from deal to deal, since it hinges on the company, what they do, and their particular metrics. So there's no single answer that works for everyone. All right.
All right, that's great. Thanks, John, and congratulations. Appreciate it.
Good morning, everyone. Good morning, Tums. I believe you had a fantastic quarter, and I can't wait to write about it. I do have a few questions on the financials. First off, you brought up a shift in average selling prices during the quarter. What I'd like to know is how the new levels compare with the previous ones.
Sure, this shift actually took place some time ago, but at the point when we first rolled it out, rolled out OmniOne, the price up until, I suppose, until November of last year was 3,495 for the complete system; and then we also had the OmniOne Core system; now that we've rolled out OmniOne for Quest, our pricing has changed. OmniOne for Quest is now $2,595. OmniOne Core is $2,495; and the complete system is... But prior to the original pricing, when we were selling OmniOne units during the pre-order period, those the post-complete system went for $2,595 as a complete system to pre-order customers. And that price was raised to $3,495 in November of last year. And so many of the early backlog, the early orders, were sold at a lower price. And we built up a sizable backlog from that pre-order period that I believe began in 2023. So it's a substantial backlog that we fulfilled across multiple quarters and... And a number of those early orders carried a lower pricing, while the new pricing, which took effect in November of last year, was 3,495; so that's where our market margin, the main factor behind our margin going up relative to.
Regarding the quarters from the prior year — alright, thanks. As you move toward becoming profitable, how would you characterize the rate at which you're currently burning cash?
Yeah, the math is something you can work out yourself. Broadly, running the numbers should land you near $1 million per month. That figure is somewhat higher now that we've completed our IPO and are still settling into life as a publicly traded entity. Expenses have grown somewhat, particularly when set against, naturally, the period prior to listing. We intend to rein that in somewhat; yet indeed, that's approximately what the financial statements let you deduce.
Alright, thanks. And finally, I saw in the 10Q that the balance sheet dated March 31st, 2026 is marked as revised. Could you explain what that actually means?
Sure, that ties to the fact that we switched audit firms. Aydin Ramp is an excellent outfit. We're glad to be working with them. They then performed a review of our quarter, um, and of the opening balance for that quarter. And uh, following their review, we ended up making a few adjustments, uh, nothing material, so we did what I'd describe as a small R revision, having nothing to do with any operational metrics, revenues, costs, or anything of that sort. It solely concerns how we classify those complicated funding systems instruments we hold, plus a derivative liability tied to them, which is comparable notes — very technical, but that's the source of it.
Sounds great. Thanks so much, everyone. Appreciate it, Andy.
Thank you, operator. And thanks to all of you for being here today. I'll wrap up by noting that we view the first quarter of fiscal 2027 as among the most commercially successful periods in our company's recent past. Order volume picked up pace, margin levels grew, and our technology reached the U.S. Marine Corps, Tesla, NASA, plus an expanding group of healthcare collaborators. That represents an impressive mix of customers as we take OmniOne past the consumer gaming space alone and turn it into a platform serving many uses across numerous industries — consumer, defense, enterprise, healthcare, and beyond. Our gratitude goes out to the team, the partners, and the shareholders for sticking with us. What we got done during this quarter makes us proud, and we're eager to share more news over the next few months. Should any question of yours have gone unanswered during today's call, get in touch with our investor relations folks over at MZ Group — they'll gladly help you out. Thanks once more for being here with us, and enjoy the rest of your day.
Thanks. That brings today’s teleconference to a close. At this point, please go ahead and disconnect your line, and enjoy a wonderful day. We appreciate your participation today. This live transcript is generated automatically, with no human intervention or review.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Virtuix Holdings Inc. transcript - plus 131,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Virtuix Holdings Inc. earnings transcripts and 131,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.